Skip to main content
Clinical Trials/CTRI/2024/07/070064
CTRI/2024/07/070064Not yet recruitingPhase 3 4

Comprative study of pushkarmoola churna and vasa swarasa in management of tamak shwasha

Post graduate institute of ayurveda DSRRAU Jodhpur1 site in 1 country60 target enrollmentStarted: July 17, 2024Last updated:

Trial Snapshot

Phase
Phase 3 4
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Estimate of asthma frequency attack which is reduced by the intervention

Study Overview

Brief Summary

Comparative study of Pushkar Moola Churna And Vasa Sawaras in Tamak Shwasa (Bronchial Asthma)

Dose Pushkar moola churna 1-3 gm

Dose Vasa Swarasa 5-10 ml

Age Criteria 30-60 years

End result Reduce attack of Bronchial Asthma And improving the quality of life

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
30.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Age between 30 to 60 years Classical symptoms of Tamak Shwasa with emphasis to symptoms of bronchial asthma like dyspnoea, wheezing, chest tightness and cough worsening particularly at night and in early hours of the morning History of frequency of attack of once a week or more.

Exclusion Criteria

  • Tuberculosis Bronchial Carcinoma COPD Pleural Effusion Cardiac Asthma Emphysema.

Outcomes

Primary Outcomes

Estimate of asthma frequency attack which is reduced by the intervention

Time Frame: 45 days

Secondary Outcomes

  • Improving the quality of life and reduce dependency on other medicine(45 days)

Investigators

Sponsor
Post graduate institute of ayurveda DSRRAU Jodhpur
Sponsor Class
Government medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Anish chouhan

Post graduate institute of Ayurveda DSRRAU Jodhpur

Study Sites (1)

Loading locations...

Similar Trials